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Constriction velocities of renal afferent and efferent arterioles
of mice are not related to SMB expression.
Background. Constriction of renal arterioles contributes sig-
nificantly to the control of perfusion and glomerular filtration.
Afferent but not efferent arterioles express smooth muscle
myosin heavy chain B (SMB) (with a 5′-insert of seven amino
acids). The aim of the present study was to investigate (1) the
constriction characteristics of afferent and efferent arterioles
under physiologic load and (2) whether expression of SMB may
causally contribute to these constriction characteristics.
Methods. We compared constriction parameters [constriction
amplitude, maximal rate of constriction velocity (“dc/dtmax”),
and time to half-maximal constriction (t1/2) of in vitro perfused
renal afferent and efferent arterioles of wild-type (smb(+/+)]
and homozygous SMB knockout [smb(−/−)] mice upon stimu-
lation with angiotensin II (Ang II) (10−8 mol/L) and potassium
chloride (KCl) (100 mmol/L). SMB expression was investigated
by double-labeling immunofluorescence.
Results. Contraction amplitude and dc/dtmax of mouse affer-
ent arterioles upon Ang II stimulation were significantly greater
compared to efferent arterioles. However, constriction ampli-
tudes, dc/dtmax, and t1/2 of afferent as well as efferent arteri-
oles upon Ang II stimulation were similar in smb(+/+) and
smb(−/−) mice. Constriction amplitudes upon KCl stimula-
tion of afferent arterioles were similar in both smb(+/+) and
smb(−/−) mice. Furthermore, KCl-induced dc/dtmax and t1/2 of
afferent arterioles were similar in both smb(+/+) and smb(−/−)
mice. SMB expression could be detected in afferent but not
efferent arterioles in smb(+/+) mice. No SMB expression in
either arteriole could be observed in smb(−/−) mice.
Conclusion. Our results suggest that the presence of differ-
ent alternatively 5′-spliced smooth muscle-myosin heavy chain
(SM-MHC) isoforms does not dominate the different contrac-
tile features of physiologically loaded renal afferent or efferent
arterioles.
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Type II myosin is the molecular motor which causes
smooth muscle cell (SMC) contraction by cyclic interac-
tion with actin and hydrolysis of adenosine triphosphate
(ATP). The native myosin II consists of two heavy chains
(myosin heavy chain, MHC) with around 200 kD each,
which revealed a 140 nm alpha-helical “rod” domain and
a pear-shaped N-terminal “head” domain with around
20 nm length. Two pairs light chains (myosin light chain,
MLC) with 17 kD (essential MLC) and 20 kD (regula-
tory MLC) are noncovalently associated with each MHC
close to the head domain [1, 2].
Three different MHC genes are expressed in SMCs,
namely, SM-MHC as well as MHC which are also ex-
pressed in nonmuscle (NM) cells (NM-MHCA and NM-
MHCB [3–5]). SM-MHC is exclusively expressed in
SMCs and located on the human chromosome 16p13.13
[6]. Various MHC isoenzymes have distinct functions in
SMCs. They form different contractile systems which are
recruited during phasic contraction (the SM-MHC) or
during tonic contraction upon sustained activation (the
NM-MHC isoenzymes) [7, 8].
The SM-MHC gene transcript is alternatively spliced
at both the 3′-(carboxy-terminal myosin tail) and at the
5′-end (amino-terminal head domain). Inclusion of a 39
nucleotide exon which encodes nine amino acids at the
most 3′-terminus generates the translation of a SM-MHC
isoenzyme with 1443 amino acids and around 200 kD
(SM2) with a shortened tail region. Exclusion of this
exon causes the translation of an elongated tail with 1477
amino acids and around 204 kD (SM1), containing a non-
helical tailpiece domain with a phosphorylatable serine
residue [9–11].
5′-splicing of SM-MHC is accomplished by excision
of a highly conserved exon with 21 nucleotide (seven
amino acids) causing a shortened flexible surface loop
(loop 1) close to the ATP-binding 25K/50K junction [12–
14]. SM-MHC without the 5′-insert were designated as
“SMA” isoforms (SM1A and SM2A), those with 5′-insert
as “SMB” forms (SM1B and SM2B).
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Alternative 3′-splicing in the carboxy terminus of SM-
MHC isoforms seems not to be associated with mo-
tor properties of myosin [15] or shortening velocity of
smooth muscle preparations [16]. However, alternatively
5′-spliced myosin isoenzymes revealed different kinetic
and conferred distinct contractile features to muscle
preparations. Due to the proximity to the ATP binding
pocket, the length of loop 1 may regulate the rate of
adenosine diphosphate (ADP) release from the catalytic
domain and, therefore cross-bridge detachment [17], thus
determining Vmax [18] and the duration of the duty cy-
cle [19]. In fact, SMB (with 5′-insertion and elongated
loop 1) revealed a reduced duration of the duty cycle,
increased shortening velocity as well as increased actin-
activated ATPase activity and velocity of actin filament
sliding in the in vitro motility assay [13, 20, 21]. In a re-
cently generated knockout mouse model with targeted
ablation of exon 5b [22], the SMA isoenzymes were the
sole expressed SM-MHC isoenzymes which conferred
decreased contraction kinetics to smooth muscle prepa-
rations. In the same animal model, addition of magne-
sium ADP (MgADP) revealed a stronger effect on the
force-generating states of SMA [15], supporting the hy-
pothesis that a shorter loop 1 releases ADP slower and
increases the duration of the duty cycle. Please note, how-
ever, that results of these studies reflect the kinetic fea-
tures of myosin in vitro or under unloaded rather than
under physiologically loaded conditions.
Renal afferent and efferent arterioles express different
alternatively 5′- and 3′-spliced MHC isoforms. Afferent
arterioles expressed SM1, SM2, SMA, and SMB, while ef-
ferent arterioles expressed mainly SM1 and SMA [23, 24].
In a recent study [24], SMB expression in afferent arteri-
oles was associated with enhanced constriction velocity of
afferent arterioles upon angiotensin II (Ang II) or nore-
pinephrine stimulation. However, it is not clear, whether
the presence of SMB or the different microstructures and
responsiveness to Ang II and norepinephrine [25, 26] of
renal afferent and efferent arterioles are mainly responsi-
ble for the different constriction velocities. To answer this
question, we examined Ang II responsiveness of effer-
ent arterioles and the Ang II and KCl responsiveness of
afferent arterioles of wild-type [smb(+/+)] and homozy-
gous SMB knockout [smb(−/−)] mice. While there was a
significant difference of Ang II–induced constriction am-
plitude and velocity between renal afferent and efferent
arterioles, we did not observe any significant difference
of constriction parameters of afferent and efferent arte-
rioles between smb(+/+) and smb(−/−) mice.
METHODS
Animal model
We used a homozygous SMB knockout mouse model
(smb−/−) which has been recently introduced [22]. The
homozygous SMB knockout and the corresponding wild-
type mice (smb+/+) were generated by breeding het-
erozygous SMB knockout mice. Animals were fed with
standard mouse chow and allowed free access to tap wa-
ter. All animal procedures adhered to the guidelines for
care and handling of animals established by the United
States Department of Health and Public Services and
published by the National Institutes of Health.
Constriction studies of renal afferent
and efferent arterioles
Physiologic salt solution (PSS) was used with the fol-
lowing composition: NaCl 115, NaHCO3 25, K2HPO4
2.5, CaCl2 1.3, MgSO4 1.2, and glucose 5.5 (mmol/L).
The KCl solution consisted of 100 mmol/L KCl, whereby
95 mmol/L NaCl were substituted by KCl. Dulbecco’s
modified Eagle’s medium (DMEM) (1000 mL) was sup-
plied with 100 mg streptomycin, and 100000 U penicillin.
The bicarbonate buffered solution was equilibrated with
5% CO2 and 95% O2. The pH was adjusted to 7.4 after
addition of bovine serum albumin (BSA). The oxygen
partial pressure was below 200 mm Hg in the perfusion
and bath solution during the experiment. The pH was sta-
ble. The concentration of BSA in DMEM, which was used
for dissection, and in PSS (bath solution) was 0.1%. The
perfusate of the arterioles consisted of PSS with a BSA
concentration of 1%. BSA was obtained from SERVA
Electrophoresis (Heidelberg Germany). Ang II, DMEM,
streptomycin, and penicillin were from Sigma-Aldrich
(Mu¨nchen, Germany).
Male mice (body mass was 21 to 33 g and age was
between 12 and 15 weeks) were used in this study. Af-
ter killing the animal, the kidneys were immediately re-
moved and sliced along the corticomedullary axis. The
arterioles were prepared at 4◦C in DMEM, which was
enriched with 0.1% albumin. The dissection procedure
of the afferent and efferent arterioles was the same as
described before [27]. The macula densa, the adjacent
parts of the tubule, and the glomerulus were preserved. In
case of the dissection of an afferent arteriole the efferent
arteriole was removed by cutting close to the glomeru-
lus. The same was done with the afferent arteriole when
using the efferent arteriole for the experiment. This as-
sured standard conditions in regard to the total vascu-
lar resistance of preparation, and consequently the flow.
The preparation was transferred into a thermoregulated
chamber (volume 1.5 mL) (VETEC, Rostock, Germany)
on a stage of an inverted microscope (Axiovert 100) (Carl
Zeiss, Oberkochen, Germany). The perfusion system al-
lowed movement and adjustment of concentric, holding
and perfusion pipettes (Luigs & Neumann, Ratingen,
Germany). The pipettes were made by customizing glass
tubes (Drummond Scientific Company, Broomall, PA,
USA). The holding pipette into which the free end of the
arteriole was aspirated had an aperture of roughly 26 lm
at the tip and a constriction of about 20 lm. The inner
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perfusion pipette with an aperture of 5 lm was advanced
into the lumen of the arteriole. The perfusion pipette was
connected to a reservoir containing the perfusion solu-
tion and to a manometer. Afferent arterioles were per-
fused from the free end with a pressure of 80 mm Hg in
the pressure head. Efferent arterioles were perfused ret-
rograde from the free, cut end with a pressure of 60 mm
Hg. To test the autoregulatory behavior of the afferent ar-
terioles we measured the response of afferent arterioles
diameter to stepwise increased pressure. The diameter
of afferent arterioles increased nonlinearly with increas-
ing pressure. The pressure-diameter curve showed a flat
course for most of the investigated afferent arterioles for
pressures higher than 80 mm Hg in the pressure head. We
conclude from this course that we are at the lower end of
the physiologic pressure range when using a pressure of
80 mm Hg in this perfusion setup. The value of the pres-
sure depends on the size and length of the tubes and the
perfusion pipette located between the pressure head and
the arterioles. Therefore, pressure-diameter curves are
determined for each experimental setup. If perfusion was
not achieved within 90 minutes after the mouse was killed,
the experiment was terminated. Twenty minutes were al-
lowed for adaptation after starting perfusion and gradual
heating. Only arterioles with a remaining basal tone were
used. Hypoxic or otherwise injured vessels were readily
identified by pronounced vasodilatation. The viability of
the afferent arterioles was tested by applying 100 mmol/L
KCl at the beginning of the experiment, which induced
strong constrictions of afferent but not of efferent arte-
rioles [cf., 28, 29]. Ten minutes after the viability test,
the luminal diameters were recorded and the constric-
tion experiments started. First, KCl, then Ang II–induced
constrictions were investigated in each afferent arteriole.
Only one arteriole was used from each animal.
Experimental protocols
The constriction of afferent arterioles was induced by
depolarization of the preparations with a 100 mmol/L KCl
solution applied from the bath side. Further, the constric-
tion response to a bolus application of Ang II of afferent
and efferent arterioles was determined by applying Ang
II in a concentration of 10−8 mol/L from the bath side.
Since KCl and Ang II induce constriction via different
pathways, the comparison of the contractile responses
between the two stimuli gives an idea about their influ-
ence on the observed contractile properties. KCl and Ang
II were always given in the same order, first, KCl, then
Ang II in afferent arterioles. Pilot experiments did not
show any effect of the KCl constriction on Ang II effects
or vice versa. There were only one KCl and one Ang II
application in each arteriole.
Signals were recorded on SVHS video tapes (video
recorder AG-MD 830) (Panasonic, Kadoma City, Japan).
The magnification results from an objective (×40) (Carl
Zeiss) and projection (×1) on a 0.3 inch chip digital cam-
era (CB-3803S) (GKB, Tai Chung, Taiwan). Video se-
quences were digitized using a frame grabber card (UDT
55-LC-EZ-50) (Data Translation, Marlboro, MA, USA).
Pictures were taken every 300 mseconds and the ves-
sel diameters were determined using a customized soft-
ware (Dr. H. Siegmund, Johannes-Mu¨ller-Institute of
Physiology, Humboldt-University of Berlin, Germany).
The equipment allowed a resolution of 0.2 lm of the
vessel structures. The luminal diameter of the arteri-
oles was determined for each picture. These data served
for analysis of the course of the constriction after KCl
and Ang II application, including the time to half-
maximal constriction (t1/2). Further, the maximum of
the constriction velocity was assessed using a customized
software (Dr. T. Wronski, Johannes-Mu¨ller-Institute of
Physiology, Humboldt-University of Berlin, Germany).
The time series were smoothed by applying a moving
average (three-point window). Then, the first deviation
of the averaged curve was calculated, which served for
the assessment of the maximum constriction velocity
(dc/dtmax).
Immunfluorescence analysis of SM-MHC isoforms
Cryostat sections 5 lm thick were prepared with a Jung
CM 2200 cryostat (Leica, Wetzlar, Germany). Sections
were fixed in 4% formaldehyde in 0.1 mol/L phosphate
buffer, pH 7.4, for 15 minutes at room temperature.
To suppress unspecific labeling, cryosections were prein-
cubated in 20 mmol/L Tris-HCl, pH 8.4, 130 mmol/L
NaCl, 0.05% Tween-20, 0.02% NaN3, and 1% BSA
for 20 minutes at room temperature. Immunolabel-
ing was performed for 2 hours at 37◦C with a rab-
bit anti-SMB antibody raised against the seven amino
acid insert (QGPSFAY) (rat and mouse sequence) lo-
cated at the 25K/50K junction of SM-MHC (aSMB)
(0.05 to 7.5 lg/mL), with previously shown specificity
[30], and antismooth muscle actin antibody (clone asm-
1) (Boehringer, Mannheim, Germany) (0.5lg/mL). For
immunodetection, primary antibodies were visualized
by staining with Alexa-conjugated species-specific sec-
ondary antibodies (Alexa488 and Alexa594) (Molecular
Probes, Leiden, The Netherlands) (diluted 1:1000) for
1 hour at 37◦C. Primary and secondary antibodies were
diluted in 20 mmol/L Tris-HCl, pH 8.4, 130 mmol/L NaCl,
0.05% Tween-20, 0.02% NaN3, and 1% BSA. Immunola-
beling was evaluated with an Axioplan fluorescence mi-
croscope (Carl Zeiss) using appropriate filter systems and
a fluorescence imaging system (ColourView 12).
Immunofluorescence analysis of renin expression
Immunofluorescent staining for renin was performed
on 10 lm thin cryosections of mouse kidneys, which were
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Fig. 1. Comparison of the time courses of the
angiotensin II (Ang II)–induced (10−8 mol/L)
constriction of afferent (N = 9) and efferent
(N = 6) arterioles in smb(+/+) mice. Abso-
lute luminal diameters (left) differed signifi-
cantly (P < 0.05) between both groups. Con-
striction amplitude of afferent arteriole (rela-
tive luminal diameter right) was significantly
higher (P < 0.05). The arrows indicate the
start of the constriction. Data are presented
as mean ± SEM.
produced by slicing along the corticomedullary axis. Sec-
tions were fixed with 4% paraformaldehyde/phosphate-
buffered saline (PBS) for 10 minutes and washed in
PBS for 10 minutes. Unspecific binding of the antibod-
ies was prevented by incubation of sections with block-
ing solution containing 3% BSA and 0.1% Triton-X100.
Primary rabbit antirenin antibody was a generous gift
of Professor Tadashi Inagami (Vanderbilt University,
Nashville, TN, USA) and was used in the 1:300 dilution at
4◦C overnight. After three consecutive 10-minute wash-
ing periods, the secondary fluorescein isothiocyanate
(FITC)-labeled antirabbit antibody (Merck Biosciences,
Darmstadt, Germany) was used in 1:500 dilution for
2 hours at room temperature. Slides were mounted with
Vectashield-4′,6-diamino-2-phenylindole (DAPI) (Vec-
tor Laboratories, Burlingame, CA, USA) and visualized
using inverted fluorescence microscope (Axiovert A 100)
(Carl Zeiss) and a fluorescence imaging system (Meta-
Morph(tm)) (Universal Imaging Corporation, Downing-
town, PA, USA). The total magnification of the optical
and imaging system (objective 4×, high-sensitivity dig-
ital camera, model 2.3.2) (Diagnostic Instruments, Ster-
ling Heights, MI, USA) allowed the visualization of about
one third of the total area of the renal cortex. The resolu-
tion of the grabbed pictures was 7.2 pixel/lm. Black and
white pictures (eight-bit) were analyzed using the soft-
ware ImageJ (National Institutes of Health, Bethesda,
MD, USA). Fluorescent areas were detected by applying
a binary threshold. The analysis included the calculation
of the total fluorescent area, the average size of fluores-
cent dots, and the area fraction (percentage of the total
fluorescent area in relation to the total area of the field).
Three slides, which were cut with a distance of 100 lm,
were analyzed in each animal. The median of the three
values of the parameters was used for further statistical
analysis.
Statistics
The Brunner test for nonparametric analysis of longi-
tudinal data was used to test for time-dependent changes
in the arteriolar diameter [one-way analysis of variance
(ANOVA)], to test for differences in the luminal diam-
eters between the groups, and to check for differences
in the time-dependent changes in diameter between the
groups (two-way ANOVA). The Wilcoxon test for non-
paired data was applied for the comparison of indepen-
dent measurements of the dc/dtmax, t1/2, and parameters
of the immunofluorescence analysis of renin expression.
The same test was used for comparison of diameters of
the different groups in the steady state during the control
situation. Data are presented as mean ± SEM.
RESULTS
Different constriction kinetics of afferent and efferent
arterioles of mouse kidney
The luminal diameters of efferent arterioles were
smaller compared to afferent arterioles at the start of
the experiment of wild-type animals [smb(+/+)] (P <
0.05) (Fig. 1). We observed statistically significant (P <
0.05) differences of the constriction features of efferent
arterioles compared to afferent arterioles of smb(+/+).
The time course of the constriction was flat in efferent
arterioles in comparison with afferent arterioles (Fig. 1).
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Table 1. Maximal rates of constriction velocities (dc/dtmax) and time to half-maximal constriction (t1/2) of afferent and efferent arterioles of
normal mice [smb(+/+)] and homozygous SMB knockout mice [smb(−/−)] upon angiotensin II (Ang II) and KCl stimulation.
Ang II (10−8 mol/L) KCl (100 mmol/L)
dc/dtmax Afferent arteriole lm/sec Efferent arteriole lm/sec Afferent arteriole lm/sec
smb(+/+) −3.0 ± 0.3 (9)a −1.4 ± 0.2 (6) −3.4 ± 0.4 (9)
smb(−/−) −2.7 ± 0.4 (10)a −1.3 ± 0.2 (8) −3.7 ± 0.4 (11)
t1/2 Afferent arteriole seconds Efferent arteriole seconds Afferent arteriole seconds
smb(+/+) 2.6 ± 0.5 (9)a 5.6 ± 1.4 (6) 3.5 ± 0.6 (9)
smb(−/−) 2.7 ± 0.4 (10)a 6.0 ± 0.8 (8) 3.6 ± 0.6 (11)
Values are mean ± SEM with the number of arterioles measured in parentheses.
aP < 0.05 comparing afferent versus efferent arterioles.
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Fig. 2. Time courses of angiotensin II (Ang
II) (10−8 mol/L)–induced constriction in
isolated, perfused afferent arterioles in
smb(−/−) (N = 10) and smb(+/+) mice
(N = 9). Absolute diameters (lm, left panel)
did not differ significantly between both
groups. There were no differences in the Ang
II response (see relative changes of luminal di-
ameters, right panel). The arrows indicate the
start of the constriction. The inserted graph
on the right panel demonstrates the courses
for the beginning of the constriction in higher
time and amplitude resolution. Data are pre-
sented as mean ± SEM.
The maximum constriction velocity dc/dtmax of efferent
arterioles was significantly (P < 0.05) smaller compared
to afferent arterioles upon Ang II stimulation (Table 1).
In addition, time to half-maximal constriction (t1/2) of
afferent arterioles was significantly (P < 0.05) smaller
than t1/2 of efferent arterioles upon Ang II stimulation
(Table 1).
Loss of SMB did not alter the contractile features
of afferent and efferent arterioles of mouse kidney
The complete ablation of the SMB isoform in
smb(−/−) mice provided the opportunity to selectively
investigate the physiologic role of 5′-spliced MHC isoen-
zymes by comparison of the constriction mechanics of re-
nal arterioles of smb(−/−) with smb(+/+) mice. Control
values of the luminal diameter of afferent and efferent
arterioles were similar before the start of the constriction
experiments in smb(−/−) and smb(+/+) mice (Figs. 2
to 4).
We compared the constriction amplitude, dc/dtmax as
well as the t1/2 of afferent arterioles of smb(+/+) and
smb(−/−) mice to Ang II stimulation. Ang II (10−8
mol/L) applied from the bath side reduced the luminal
diameter of afferent arterioles of smb(−/−) to a simi-
lar extent observed in smb(+/+) (Fig. 2). Furthermore,
dc/dtmax and t1/2 of afferent arterioles upon Ang II stim-
ulation were similar in both groups (Table 1).
The same observation [i.e., no different contractile fea-
tures between smb(+/+) and smb(−/−)] could be made
with efferent arterioles. Luminal diameters prior the start
of the experiment and constriction amplitudes (Fig. 3),
dc/dtmax as well as t1/2 upon Ang II stimulation were com-
parable in both mice groups (Table 1).
Furthermore, we determined the vasoconstriction re-
sponses of afferent arterioles to KCl depolarization.
KCl elicited an almost complete constriction response
(Fig. 4). This observation was similar in both smb(+/+)
and smb(−/−). Please note that there were no differ-
ences of dc/dtmax and t1/2 of afferent arterioles between
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Fig. 3. Time courses of angiotensin II (Ang
II) (10−8 mol/L)–induced constriction in ef-
ferent arterioles in smb(−/−) (N = 8) and
smb(+/+) mice (N = 6). Absolute diameters
(lm, left panel) did not differ significantly be-
tween both groups. There were no differences
in the Ang II sensitivity (see relative changes
of luminal diameters, right panel). The arrows
indicate the start of the constriction. Data are
presented as mean ± SEM.
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Fig. 4. Time courses of KCl (100 mol/L)–
induced constriction in isolated, perfused af-
ferent arterioles in smb(−/−) (N = 11) and
smb(+/+) mice (N = 9). There were no dif-
ferences in the course of the constriction be-
tween either the groups. The arrows indi-
cate the start of the constriction. The inserted
graph on the right panel demonstrates the
courses for the beginning of the constriction
in higher time and amplitude resolution. Data
are presented as mean ± SEM.
smb(+/+) and smb(−/−) (Table 1). In addition, dc/dtmax
of afferent arterioles was not significantly different from
Ang II–induced constriction (Table 1).
Immunofluorescence analysis of SMB expression in renal
arterioles
To detect the differential SMB expression in af-
ferent and efferent arterioles of the mouse, and
to demonstrate the absence of SMB expression in
smb(−/−) mice, immunofluorescence microscopy of
cryostat sections of kidneys dissected from smb(+/+)
and smb(−/−) was performed using a double-labeling
method. The specific antismooth muscle actin anti-
body was used to identify blood vessels, and the
anti-SMB antibody was used for simultaneous detec-
tion of the SMB isoform expressed in the kidney
vessels.
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Fig. 5. Immunofluorescence micrographs of mouse kidneys of smb(+/+) (A and B) and smb(−/−) (C and D), double-labeled with anti-smooth
muscle actin (0.5 lg/mL) (A and C) and anti-SMB (7.5 lg/mL) (B and D) antibodies. Primary antibodies were visualized with species-specific
secondary antibodies conjugated with Alexa488 (A and C, green) and and Alexa594 (B and D, red). Abbreviations are: glom, glomerulus; aff,
afferent arteriole; eff, efferent arteriole.
Afferent and efferent renal arterioles were stained with
anti-smooth muscle actin in wild-type and SMB knock-
out animals (Fig. 5A and C). The types of renal blood ves-
sels were identified according to their location (close to
the glomerulus) and their wall thickness (afferent arteri-
oles have a higher wall thickness than efferent arterioles).
In wild-type mice, only afferent, but not efferent arteri-
oles crossreacted with the anti-SMB antibody (Fig. 5B)
demonstrating the differential expression pattern of SM-
MHC isoenzymes in renal afferent and efferent arteri-
oles. As expected, neither afferent nor efferent arterioles
of smb(−/−) reacted with the SMB antibody (Fig. 5D).
Immuofluorescence analysis of renin expression in renal
arterioles
Renin analysis of mouse kidneys obtained from
smb(−/−) and smb(+/+) did not show significant differ-
ences. Total fluorescent area of smb(−/−) and smb(+/+)
was 3340 ± 420 lm2 and 3074 ± 921 lm2, respectively.
Average size of the fluorescent dots of smb(−/−) and
smb(+/+) was 30.6 ± 4.8 lm2, and 25.4 ± 5.02 lm2, re-
spectively. Area fraction of smb(−/−) and smb(+/+) was
1.25 ± 0.16% and 1.18 ± 0.35%, respectively. Values are
means ± SEM of eight animals per groups.
DISCUSSION
Our results demonstrate that maximal constriction ve-
locity (dc/dtmax) of mouse afferent arteriole upon Ang II
was significantly higher than dc/dtmax of mouse efferent
arteriole. A comparable result has also been observed
with the corresponding rat arterioles [24]. The different
contraction kinetics of afferent and efferent arterioles is
in line with their physiologic function. Afferent arterioles
regulate glomerular inflow resistance and have to con-
strict rapidly enough to balance fluctuations of systolic
blood pressure. Efferent arterioles regulate glomerular
outflow resistance, are not prone to rapid changes of
blood pressure, and contract more tonically. In addition,
we demonstrated that the mouse expressed SMB in re-
nal afferent, but not efferent, arterioles, which is in close
agreement with the rat renal blood vessels [24].
The aim of the present study was to investigate
whether the different 5′-alternatively spliced smooth
muscle myosin isoenzymes are causally related to the
different contractile features of afferent and efferent ar-
terioles. In fact, biochemical and kinetic properties of
SMB [29, 31, 32] as well as some observations during
physiologic experiments [22, 31, 33] may predict a higher
constriction velocity of afferent compared to efferent
arterioles.
The results of our study presented herein, however,
suggest that the expression of 5′-inserted smooth mus-
cle myosin may not be related to the higher contractile
features of mouse afferent compared to efferent arteri-
oles, as suggested previously [24]: we clearly show that
the constriction amplitude, t1/2, and dc/dtmax values of af-
ferent arterioles under physiologic load upon Ang II and
KCl activation remain similar in normal and homozygous
SMB knockout mice.
We cannot exclude completely that compensatory
mechanisms, which are frequently observed in gene tar-
geting studies (e.g., up-regulation or differential expres-
sion of regulatory thin filament proteins or MLC17
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isoforms [c.f., 34]) could have balanced the predicted in-
hibitory effect of SMB ablation on renal arteriole con-
striction. Such a hypothetical compensatory mechanism,
however, must then be focused selectively on the af-
ferent arteriole since the contractile features of effer-
ent arterioles remain similar in both smb (+/+) and
smb(−/−). Furthermore, changes of the normal expres-
sion of alternatively 3′-spliced SM-MHC isoforms could
not account for our observations, since those myosin
isoenzymes seems not to be associated with motor prop-
erties of myosin [15] or shortening velocity of smooth
muscle preparations [16]. Thus, it is unlikely that compen-
satory mechanisms could have obscured the physiologic
role of the deleted SMB in renal arterioles. Consequently,
even in the absence of the highly active SMB isoenzyme,
the physiologic function of afferent arterioles is main-
tained, which is in close agreement with the normal phe-
notype, organ functions, and life span of smb(−/−) mice
[22, 34]. Indeed, the presence of fast SMB or slow SMA
isoforms in smooth muscle is not necessarily associated
with a correspondingly fast or slow contraction of smooth
muscle preparations [14, 16, 32, 34, 35], suggesting that
other factors could well dominate the effects of alterna-
tively 5′-spliced myosins.
The reason for the absence of any effect of alternatively
5′-spliced smooth muscle myosin isoforms on contrac-
tile features of afferent arterioles is not completely clear.
Please note, that we investigated constriction velocities
under physiologic pressure load. However, alternatively
5′-spliced smooth muscle myosin isoforms (or any other
myosin isoform) revealed large differences only in vitro
[13, 20, 21] and in muscle in particular under unloaded
conditions [22, 31, 33]. Investigating the force-velocity
relationship of smooth muscle preparations with differ-
ent amounts of SMB and SMA, however, revealed just
marginal differences of shortening velocity under high
load [31, 34]. Since we investigated contractile parame-
ters of our arterial preparations under pressure load in a
physiologic range, a dominant modulatory role of alter-
natively 5′-spliced myosin isoforms on the regulation of
contraction velocity could not be expected.
Hence, alternatively 5′-spliced SM-MHC isoenzymes
may not determine the different contractile features of
efferent and afferent arterioles under physiologic con-
ditions. Our observations contradict the suggestion that
it is the SMB expression which confers the higher con-
tractile state to afferent arterioles [24]. Rather, different
microstructures and activation mechanisms of pre- and
postglomerular arterioles could well be responsible for
the different contractile properties. With the exception of
the distal rennin-producing juxtaglomerular cells, affer-
ent arterioles are densely covered by contractile smooth
muscle cells which contain large amounts of myofila-
ments with abundant thick filaments. Efferent arterioles,
in contrast, have a sparse layer of smooth muscle cells
which revealed a few myofilaments associated with very
small amounts of thick filaments [23, 36]. A function-
ally relevant substitution of SMCs by renin-producing
noncontractile cells in afferent arterioles [c.f., 23] could
be excluded, since renin remained unchanged in our
preparations.
Thus, the ability of afferent arterioles to generate force
may be much higher than of efferent arterioles. Since the
velocity of shortening declines with the force a muscle has
to generate [37], the velocity to shorten against a given
load of efferent arterioles should indeed be much slower
than afferent arterioles. Afferent arterioles, but not ef-
ferent arterioles, revealed a myogenic response, could
be activated by KCl depolarization [29], and expressed
voltage-gated T- and L-type Ca2+ channels [25, 26]. Ang
II activates Ca2+ entry through depolarization and acti-
vation of voltage-gated Ca2+ channels in afferent arteri-
oles, while in efferent arterioles Ang II stimulated Ca2+
influx without depolarization via store-operated Ca2+ in-
flux [25]. Contraction activation of pre- and postglomeru-
lar arterioles by Ang II, therefore, is elicited by different
cellular pathways which consequently confer different
contraction properties.
CONCLUSION
The different SMC density and myofilament structures,
as well as the different Ca2+ activation characteristics,
rather than the expression of distinct alternatively spliced
SM-MHC isoenzymes, may be the dominant determi-
nants of the specific contractile features of afferent and ef-
ferent arterioles under physiologically loaded conditions.
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